ValCor Cath
Ottawa Hills, US · Founded 2023 · Delaware corporation
Find your way into ValCor Cath
Sign up to see every warm intro you have to ValCor Cath
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ValCor Cath team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
HB
Howard BobrowExecutive
PK
P. Kasi RamanathanExecutive
EJ
Eugene JungExecutive
Board
MB
Michael BunkerBoard director
GS
Gary SmithBoard director
MP
Matthew PollmanBoard director
Reported raises · per SEC filings
Form D private placements$4.3M disclosed across 1 round · 2023
▶$4.3MraisedAug 2025 · 52 investors · BiotechnologyRule 506(b)
▶$4.3MraisedAug 2025 · 52 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Howard BobrowExecutive Officer
- Michael BunkerDirector
- P. Kasi RamanathanExecutive Officer, Director
- Gary SmithDirector
- Matthew PollmanDirector
- Eugene JungExecutive Officer, Director
- Offering amount
- $4.3M
- Amount sold
- $4.3M
- Minimum investment
- $10K
- First sale
- May 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has ValCor Cath raised?
- ValCor Cath has disclosed $4.3M raised across 1 round.
- Where is ValCor Cath headquartered?
- ValCor Cath is headquartered in Ottawa Hills, US.